RGEBX
Price
$81.09
Change
-$0.47 (-0.58%)
Updated
Sep 2 closing price
Net Assets
329.04B
RIVRX
Price
$35.93
Change
-$0.31 (-0.86%)
Updated
Sep 2 closing price
Net Assets
205.24M
Interact to see
Advertisement

RGEBX vs RIVRX

Header iconRGEBX vs RIVRX Comparison
Open Charts RGEBX vs RIVRXBanner chart's image
American Funds Growth Fund of Amer R2E
Price$81.09
Change-$0.47 (-0.58%)
VolumeN/A
Net Assets329.04B
Riverbridge Growth Investor
Price$35.93
Change-$0.31 (-0.86%)
VolumeN/A
Net Assets205.24M
RGEBX vs RIVRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RGEBX vs. RIVRX commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGEBX is a Buy and RIVRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 329B vs. RIVRX (205M). RGEBX (0.00) and RIVRX (0.00) have matching dividends . RGEBX was incepted earlier than RIVRX: RGEBX (11 years) vs RIVRX (13 years). RIVRX (1.29) is less costly to investors than RGEBX (1.09). RGEBX is a more actively managed with annual turnover of: 25.00 vs. RIVRX (6.00). RGEBX has a lower initial minimum investment than RIVRX: RGEBX (250) vs RIVRX (1000). RGEBX annual gain was more profitable for investors over the last year : 12.02 vs. RIVRX (9.92). RGEBX return over 5 years is better than : 34.83 vs. RIVRX (27.74).
RGEBXRIVRXRGEBX / RIVRX
Total Expense Ratio1.091.2190%
Annual Report Gross Expense Ratio1.091.2984%
Fund Existence11 years13 years-
Gain YTD13.5086.369212%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets329B205M160,488%
Annual Yield % from dividends0.000.00-
Returns for 1 year12.029.92121%
Returns for 3 years54.3256.6896%
Returns for 5 years34.8327.74126%
Returns for 10 years92.82160.5358%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APGE37.861.49
+4.10%
Apogee Therapeutics
CVGW27.18-0.17
-0.62%
Calavo Growers
BEN25.42-0.24
-0.94%
Franklin Resources
OVID1.23-0.05
-3.91%
Ovid Therapeutics
RKDA3.40-0.46
-11.86%
Arcadia Biosciences